mCRCMMRp/MSS CRCpancreatic ductal adenocarcinomametastatic colorectal cancersMMRp/MSSipilimumabnivolumabJohns Hopkins UniversitymKRAS-VAXoxaliplatin
…RAS-VAX with nivolumab and ipilimumab in patients with MMRp/MSS mCRC refractory to fluoropyrimidines, irinotecan, and oxaliplatin. P…